CEO, Covance Drug Development of Laboratory Corp Of America Holdings (NYSE:LH), Kirchgraber Paul R, sells 2,500 shares worth $691,375
According to Laboratory Corp Of America Holdings's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated May 10 08:21 AM, company CEO, Covance Drug Development, Kirchgraber Paul R disclosed selling 2,500 shares at a cost of $276.55. At the time of this transaction (May 06), this trade was worth $691,375 in total. As of May 06, Kirchgraber Paul R now owns 7,844 shares in total worth about $2,190,280.12.
For the last few recent trades made by Laboratory Corp Of America Holdings (NYSE:LH) CEO, Covance Drug Development, Kirchgraber Paul R, we have the following information:
- SEC Form 4 filing: Nov 04: Sold 1,500 shares at the rate of $214.14 per share. Total worth of this trade was $321,204. Total number of shares owned as of Nov 04 were 7,698
Posted by
George Daniels
on Monday May 10 2021, 10:50 AM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
